Growth Inhibition and Additive Effect to Antimalarial Drugs of

Niwat Kangwanrangsan, Gamolthip Niramolyanun, Chonnipa Praikongkatham, Pathanin Chantree, Pongsakorn Martviset, Viriya Pankao

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Antiplasmodial Compounds fromInternational journal of molecular sciences · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Niwat KangwanrangsanDepartment of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0001-6090-6689

Gamolthip NiramolyanunDepartment of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0003-3694-6087

Chonnipa PraikongkathamDepartment of Pathobiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.

Pathanin ChantreeDepartment of Preclinical Sciences, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.ORCID 0000-0003-4974-9584

Pongsakorn MartvisetDepartment of Preclinical Sciences, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.ORCID 0000-0003-4168-5950

Viriya PankaoDepartment of Preclinical Sciences, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.

Funding

Faculty of Medicine, Thammasat University, Thailand 2-03/2562

6 · The paper itself

Abstract

Malaria is a parasitic infectious disease that is endemic in many tropical countries. Even though several effective antimalarial agents have been implemented, treatment failure still occurs, and malaria continues to cause neurological complications and death, particularly in severe or drug-resistant cases. Hence, novel therapeutic agents with distinct mechanisms of action, as well as alternative chemical compounds that can overcome resistance, are still needed to improve malaria therapy. This study aimed to investigate the antimalarial activities of

Indexed as

AntimalarialsBruceaMalaria, FalciparumPlant ExtractsPlasmodium falciparumArtesunateChloroquineDrug SynergismErythrocytesHumansAntimalarialsArtesunateChloroquinePlant Extractsadditive effectartesunatechloroquinemalariamedicinal plant

Identifiers

PMID40732696

DOI10.3390/pathogens14070646

PMCPMC12301036

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.